U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted in favor of use of Bavarian Nordic's Jynneos vaccine for all adults at risk of mpox during an outbreak. Reuters Reuters

...

The recommendation of the committee is based on studies that showed vaccine effectiveness of 66%-83% for patients with full vaccination and 36%-86% for partial vaccination with no severe adverse affect.

...